Form D · Other Health Care

UVLrx Therapeutics, Inc.

Oldsmar, FL · CIK 0001546059

Offering snapshot reported Jun 12, 2018 · SEC filing

Reported sold
$40K
Offering amount: $5M
Investors reported
1
Form D · investor count
Minimum accepted
$30K
Reported outside-investor minimum
First sale
May 23, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 12, 2018Initial$40,000No comparison1SEC filing
Nov 3, 2016Initial$206,000No comparison2SEC filing
Jul 21, 2015Initial$25,200No comparison1SEC filing
Feb 18, 2015Initial$385,000No comparison6SEC filing
Sep 23, 2014Initial$144,000No comparison1SEC filing
Feb 7, 2014Initial$245,000No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-314436

Source: Form D, filed Jun 12, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Tom Di Giovanni Director, Executive
Scott Grizzle Director
R. Scott Grizzle Director, Executive
Rowland Hanson Executive
Michael Harter Director, Executive
Ryan Maloney Executive
Victor Scheeren Director, Executive
Victor Sheeren Director, Executive
Mitchell Wortzman Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
640 Brooker Creek #455
Oldsmar, FL, 34677